Ayush Ministry Gets Rs 3,712 Crore In Interim Budget

New Delhi: The interim Budget allocation for the Ayush Ministry has been increased to Rs 3,712.49 crore for 2024-25 from Rs 3,000 crore (revised estimates) in 2023-24, recording a rise of 23.74 percent.

The National Medicinal Plants Board has been allocated Rs 14.63 crore while the Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) allocated Rs 20.80 crore.

The autonomous bodies have been allocated Rs 1,848.40 crore, of which Central Council for Research in Ayurvedic Sciences has been given Rs 413.54 crore, Central Council for Research in Homeopathy Rs 144 crore, Central Council for Research in Unani Medicine Rs 228.05 crore and the All India Institute of Ayurveda has got Rs 227.20 crore.

The National Medicinal Plants Board undertakes promotional and contractual farming schemes with a view to encourage in-situ conservation and ex-situ cultivation of medicinal plants for providing raw materials of assured quality for manufacturing of ASU&H medicines.

At the initiative of the National Medicinal Plants Board, 32 State Medicinal Plants Boards in 27 states and five Union territories have been constituted for providing impetus to cultivation of high priority medicinal plants for domestic consumption as well as export.

The Pharmacopoeia Commission for Indian Medicine and Homoeopathy is a subordinate office under the Ministry of Ayush. It is an appellate authority for drug testing of all Ayush drugs in India. Further, it sets standards for all Ayush drugs which are published in the form of Pharmacopoeias.

Related Posts

Cancer cure must not be hostage to Big Pharma

In recent years, immunotherapy has expanded the limits of cancer treatment. Therapies that harness the body’s immune system to fight malignant cells have improved survival rates in cancers once considered…

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Pune:- A woman, 34, dia­gnosed with poly­cystic ovary syn­drome, or PCOS, as a teen­ager, saw her first nat­ural men­strual cycle in Feb­ru­ary—six months after start­ing Moun­jaro for weight man­age­ment. This…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients